Publication | Open Access
TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm)
18
Citations
22
References
2023
Year
In patients with unresectable multiple nodular and large HCC (single nodular diameter of >5 cm), TACE combined with target therapy and immunotherapy is safe and effective.
| Year | Citations | |
|---|---|---|
Page 1
Page 1